Changes to the 340B Program: What Covered Entities Must Know
|Audio & Reference Manual||$199.00||Add to Cart|
Understand the 340B Program and how the changes can affect multiple health care organizations.
The federal 340B Drug Pricing Program (340B Program) has grown rapidly in recent years, with more hospitals and health systems recognizing the valuable role the Program can play in expanding access to health care for patients of safety net facilities. This topic will describe recent proposed changes to the 340B Program stemming from Omnibus Guidance released by the Health Resources and Services Administration (HRSA) in August 2015. In this topic, Richard P. Church will describe the history of the Omnibus Guidance and the 340B Program more broadly, then will describe in detail the proposals contained in the Omnibus Guidance that could impact hospitals and other 340B covered entities - as well as contract pharmacies, drug manufacturers, and others - across the country. Finally, it will discuss potential next steps on the Omnibus Guidance and the future direction of the 340B Program before providing an opportunity for questions from the audience. Gain key insights into the 340B Program, including current HRSA policies and enforcement priorities, the complexities of the Program, and updates on issues that could have a significant impact on the finances of safety net facilities in the years ahead.
Richard P. Church, K&L Gates
Self Study Credit - Audio & Reference Manual
Sponsored by Lorman Education
|CLE||1.5||AZ, CA, GA, HI, IL, ME, MT, NV, VT, WA|
|CLE||1.8||MO, NJ, WV|
|OnDemand Webinar||More Info|